0001596771-19-000083.txt : 20190726 0001596771-19-000083.hdr.sgml : 20190726 20190726162440 ACCESSION NUMBER: 0001596771-19-000083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190724 FILED AS OF DATE: 20190726 DATE AS OF CHANGE: 20190726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOUSKY KENNETH W CENTRAL INDEX KEY: 0000939478 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 19978313 MAIL ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gemphire Therapeutics Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 BUSINESS PHONE: 248-980-6538 MAIL ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-07-24 0 0001638287 Gemphire Therapeutics Inc. GEMP 0000939478 KOUSKY KENNETH W 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 1 0 0 0 Common Stock 2019-07-24 4 A 0 15000 0 A 26935 D 4,472 shares previously held by the BWA Gemphire Investment Group, LLC, and 6,463 shares previously held by BWA Gemphire Investment Group II, LLC were transferred to Mr. Kousky and are now held directly. /s/ Stephanie Swan, by Power of Attorney 2019-07-26